These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 18832020
1. In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media. Ghazal HS, Dyas AM, Ford JL, Hutcheon GA. Int J Pharm; 2009 Jan 21; 366(1-2):117-23. PubMed ID: 18832020 [Abstract] [Full Text] [Related]
7. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Sunesen VH, Pedersen BL, Kristensen HG, Müllertz A. Eur J Pharm Sci; 2005 Mar 21; 24(4):305-13. PubMed ID: 15734297 [Abstract] [Full Text] [Related]
9. Estimation of intragastric drug solubility in the fed state: comparison of various media with data in aspirates. Diakidou A, Vertzoni M, Dressman J, Reppas C. Biopharm Drug Dispos; 2009 Sep 21; 30(6):318-25. PubMed ID: 19644845 [Abstract] [Full Text] [Related]
10. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. Yang W, Tam J, Miller DA, Zhou J, McConville JT, Johnston KP, Williams RO. Int J Pharm; 2008 Sep 01; 361(1-2):177-88. PubMed ID: 18556158 [Abstract] [Full Text] [Related]
11. Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid. Mellaerts R, Aerts A, Caremans TP, Vermant J, Van den Mooter G, Martens JA, Augustijns P. Mol Pharm; 2010 Jun 07; 7(3):905-13. PubMed ID: 20232903 [Abstract] [Full Text] [Related]
13. A new cocrystal and salts of itraconazole: comparison of solid-state properties, stability and dissolution behavior. Shevchenko A, Bimbo LM, Miroshnyk I, Haarala J, Jelínková K, Syrjänen K, van Veen B, Kiesvaara J, Santos HA, Yliruusi J. Int J Pharm; 2012 Oct 15; 436(1-2):403-9. PubMed ID: 22750429 [Abstract] [Full Text] [Related]
14. [Study of the acid buffering capacity of dietary components regarding food-drug interactions]. al-Behaisi S, Antal I, Morovján G, Drabant S, Plachy J, Marton S, Klebovich I. Acta Pharm Hung; 2002 Oct 15; 72(3):185-90. PubMed ID: 12494789 [Abstract] [Full Text] [Related]
15. Development of an itraconazole-loaded gelatin microcapsule with enhanced oral bioavailability: physicochemical characterization and in-vivo evaluation. Li DX, Park YJ, Oh DH, Joe KH, Lee JH, Yeo WH, Yong CS, Choi HG. J Pharm Pharmacol; 2010 Apr 15; 62(4):448-55. PubMed ID: 20604833 [Abstract] [Full Text] [Related]
16. Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation. Long CM, Tang K, Chokshi H, Fotaki N. AAPS PharmSciTech; 2019 Feb 13; 20(3):113. PubMed ID: 30761437 [Abstract] [Full Text] [Related]
18. Increased oral bioavailability of itraconazole and its active metabolite, 7-hydroxyitraconazole, when coadministered with a vitamin C beverage in healthy participants. Bae SK, Park SJ, Shim EJ, Mun JH, Kim EY, Shin JG, Shon JH. J Clin Pharmacol; 2011 Mar 13; 51(3):444-51. PubMed ID: 20400647 [No Abstract] [Full Text] [Related]
19. In vitro characterization of some biopharmaceutical properties of praziquantel. González-Esquivel D, Rivera J, Castro N, Yepez-Mulia L, Jung Cook H. Int J Pharm; 2005 May 13; 295(1-2):93-9. PubMed ID: 15847994 [Abstract] [Full Text] [Related]